BiotechTube
Home/Levicept/Kevin Johnson
KJ

Kevin Johnson

Executive Chairman

Levicept

Therapeutic Areas

Chronic PainOsteoarthritis

Levicept Pipeline

DrugIndicationPhase
LEVI-04Pain due to Osteoarthritis of the KneePhase 2

Leadership Team at Levicept

EF
Eliot Forster
CEO
SW
Simon Westbrook
Founder and CSO
FD
Francesco de Rubertis
Board Member
View full Levicept profile